Skip to content

A Randomized Study of Approaches in Total Hip Arthroplasty

A Randomized Clinical Trial of Direct Anterior Approach and Mini-Posterior Approach Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01613508
Enrollment
116
Registered
2012-06-07
Start date
2013-01-31
Completion date
2018-02-27
Last updated
2018-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Replacement

Brief summary

The primary aim of the study is to compare the results of an established, successful procedure, which is total hip arthroplasty through a mini-posterior approach to a less studied - increasingly popular procedure, which is total hip replacement through the direct anterior approach utilizing the orthopedic table.

Interventions

PROCEDUREMini-Posterior Approach

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Male or Female patients between 20 and 100 with unilateral osteoarthritis (DJD) who are surgical candidates for total hip arthroplasty 2. Study participants must be able to give informed consent.

Exclusion criteria

1. Significant proximal femoral deformity (post SCFE, Perthes, DDH), acetabular dysplasia (ANY CROWE), inflammatory arthritis, septic arthritis, osteomyelitis, prior infection of hip joint, significant leg length discrepancy (\> 4cm), osteoporosis, arthrodesis of the affected hip. 2. The presence of infections, highly communicable diseases, e.g. AIDS, active tuberculosis, venereal disease, hepatitis. 3. Significant neurological or musculoskeletal disorders or disease that may adversely affect normal gait or weight bearing. 4. Presence of previous prosthetic hip replacement device (any type). 5. Active Metastatic disease 6. Active major Psychiatric illness 7. Active Drug or alcohol abuse 8. BMI \> 40. 9. Patients that are known to be pregnant 10. Actively failing contralateral hip replacement.

Design outcomes

Primary

MeasureTime frameDescription
Activity monitors will be wornBaseline to 1 year3 monitoring sensors will be worn by the subject.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026